In mammary tumour cells expressing functionally active ErbB2, the overexpression of mutant ShcA (ShcA/3F), which lacks the three tyrosine residues (Y239/240 and Y317), strikingly affected the ability of ErbB2-transformed cells to secrete VEGF [92]. Here, ERBB2 is linked to breast cancer.